All Pharma News
BeiGene`s 2023 Responsible Business & Sustainability Report

BeiGene`s 2023 Responsible Business & Sustainability Report
BUSINESSWIRE
26 Apr 2024
Share Share
BeiGene Highlights New Hematology & Solid Tumor Data at ASCO 2024

BeiGene Highlights New Hematology & Solid Tumor Data at ASCO 2024
BUSINESSWIRE
24 Apr 2024
Share Share
BeiGene`s Tislelizumab Approved in EU for Lung Cancer

BeiGene`s Tislelizumab Approved in EU for Lung Cancer
BUSINESSWIRE
23 Apr 2024
Share Share
US FDA approves BeiGene`s esophageal cancer therapy

US FDA approves BeiGene`s esophageal cancer therapy
REUTERS
15 Mar 2024
Share Share
BeiGene looks beyond China as it secures API source, nears opening of US site

BeiGene looks beyond China as it secures API source, nears opening of US site
Anna Brown ENDPTS
14 Mar 2024
Share Share
BeiGene`s Biologic Tevimbra (tislelizumab) Receives Approval in the U.S.

BeiGene`s Biologic Tevimbra (tislelizumab) Receives Approval in the U.S.
FDA
13 Mar 2024
Share Share
First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia

First Doses of BRUKINSA® provided to Patients with Chronic Lymphocytic Leukemia
BUSINESSWIRE
13 Mar 2024
Share Share
BeiGene bumps AbbVie, J&J from top lymphoma event sponsor spot

BeiGene bumps AbbVie, J&J from top lymphoma event sponsor spot
Nick Paul Taylor FIERCE PHARMA
12 Mar 2024
Share Share
US FDA approves expanded use of BeiGene`s blood cancer drug

US FDA approves expanded use of BeiGene`s blood cancer drug
Mariam E Sunny REUTERS
08 Mar 2024
Share Share
BeiGene Announces FDA Accelerated Approval of BRUKINSA

BeiGene Announces FDA Accelerated Approval of BRUKINSA
BUSINESSWIRE
07 Mar 2024
Share Share